register

News - MedTech & Diagnostics

3D printed limb to be the more cost-effective future of prosthetics

Health Industry Hub | May 18, 2020 |

A new 3D printed prosthetic hand that could make prosthetics both light and affordable has been designed by Australian researchers at the University of Melbourne.

The team developed a prosthetic hand called ‘X-limb’ which is capable of three grasp types including a pinch, tripod, and power grasp, allowing the user to perform tasks such as grasping a mobile phone, tying a shoelace, zipping a jacket, or using scissors.

The hands weigh only 253 grams and are operated by sensors placed on the surface of the skin, or by buttons located on the wrist.

They are expected to last for at least 12 months and cost as little as $200USD in materials to produce.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to encourage Pharma, Biotech and MedTech industry professionals to take action on mental health during COVID-19. LinkedIn post.


News - MedTech & Diagnostics

‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director

Health Industry Hub | August 7, 2026 |

The leadership compass is being recalibrated as the old coordinates give way to complexity, contradiction and change. For Liz Carnabuci, […]

More


News - MedTech & Diagnostics

Department of Health halts PL changes as industry warns of device viability

Department of Health halts PL changes as industry warns of device viability

Health Industry Hub | August 7, 2026 |

The Department of Health has received the final evaluation report into the Prescribed List (PL) reforms from the Nous Group, […]

More


News - Biotechnology

argenx inks new agreement with Australian regenerative medicine biotech

Health Industry Hub | August 7, 2026 |

Immunology company argenx has entered into a new strategic partnership agreement with Monash University and Monash-originated spinout Myostellar, to develop […]

More


News - Pharmaceuticals

The human face rewriting Australia’s most common rare disease, cystic fibrosis

The human face rewriting Australia’s most common rare disease, cystic fibrosis

Health Industry Hub | August 7, 2026 |

New national data from the Australian Cystic Fibrosis Data Registry (ACFDR) has revealed a significant shift in the trajectory of […]

More


This content is copyright protected. Please subscribe to gain access.